CAC
PEPLW

Cowen and Company’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Cowen and Company’s Portfolio PEPLW Stock Details PEPLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-235,067
Closed -$7.08K – 759
2023
Q4 		$7.08K Buy
235,067
+51,172
+28% +$1.26K ﹤0.01% 426
2023
Q3 		$13.1K Buy
183,895
+2,932
+2% +$185 ﹤0.01% 428
2023
Q2 		$3.65K Buy
180,963
+49,900
+38% +$2.69K ﹤0.01% 491
2023
Q1 		$12.5K Buy
131,063
+599
+0.5% +$50 ﹤0.01% 362
2022
Q4 		$2K Buy
130,464
+200
+0.2% +$6 ﹤0.01% 572
2022
Q3 		$10K Buy
130,264
+2,507
+2% +$362 ﹤0.01% 429
2022
Q2 		$33K Buy
127,757
+9,800
+8% +$4.01K ﹤0.01% 334
2022
Q1 		$49K Sell
117,957
-5,140
-4% -$2.22K ﹤0.01% 335
2021
Q4 		$55K Buy
+123,097
New +$58.1K 0.01% 424

Other funds holding PEPLW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Cowen and Company's PEPLW Position: Q1 2024 in Review

Cowen and Company sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2024, closing a stake of 235,067 shares — an estimated $7.08K sold.

Cowen and Company first reported a position in PEPLW in Q4 2021 and held it in 9 quarters. The position peaked at $55K in Q4 2021. 1 fund tracked by Wall St. Rank holds PEPLW as of Q1 2024.

  • Cowen and Company reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2024 after selling out during the quarter.
  • Cowen and Company sold 235,067 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2024, an estimated $7.08K.
  • Cowen and Company first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 9 quarters.
  • Cowen and Company's PepperLime Health Acquisition Corporation Warrrant position peaked at $55K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.